Stoke Therapeutics Inc (STOK)
11.69
+0.13
(+1.12%)
USD |
NASDAQ |
May 02, 16:00
11.69
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics Total Return Price: 11.69 for May 2, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 02, 2024 | 11.69 |
| May 01, 2024 | 11.56 |
| April 30, 2024 | 11.03 |
| April 29, 2024 | 11.86 |
| April 26, 2024 | 12.41 |
| April 25, 2024 | 11.69 |
| April 24, 2024 | 11.66 |
| April 23, 2024 | 11.25 |
| April 22, 2024 | 11.25 |
| April 19, 2024 | 12.05 |
| April 18, 2024 | 11.65 |
| April 17, 2024 | 11.72 |
| April 16, 2024 | 12.45 |
| April 15, 2024 | 12.21 |
| April 12, 2024 | 12.77 |
| April 11, 2024 | 13.50 |
| April 10, 2024 | 12.76 |
| April 09, 2024 | 12.85 |
| April 08, 2024 | 13.00 |
| April 05, 2024 | 12.57 |
| April 04, 2024 | 12.17 |
| April 03, 2024 | 12.82 |
| April 02, 2024 | 13.08 |
| April 01, 2024 | 13.49 |
| March 28, 2024 | 13.50 |
| Date | Value |
|---|---|
| March 27, 2024 | 14.17 |
| March 26, 2024 | 10.29 |
| March 25, 2024 | 6.50 |
| March 22, 2024 | 6.30 |
| March 21, 2024 | 5.99 |
| March 20, 2024 | 5.99 |
| March 19, 2024 | 5.80 |
| March 18, 2024 | 6.08 |
| March 15, 2024 | 6.39 |
| March 14, 2024 | 6.48 |
| March 13, 2024 | 6.85 |
| March 12, 2024 | 6.63 |
| March 11, 2024 | 7.22 |
| March 08, 2024 | 7.57 |
| March 07, 2024 | 7.65 |
| March 06, 2024 | 7.97 |
| March 05, 2024 | 7.13 |
| March 04, 2024 | 6.855 |
| March 01, 2024 | 7.63 |
| February 29, 2024 | 7.74 |
| February 28, 2024 | 7.96 |
| February 27, 2024 | 8.17 |
| February 26, 2024 | 6.65 |
| February 23, 2024 | 5.94 |
| February 22, 2024 | 5.32 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
3.37
Minimum
Oct 27 2023
69.81
Maximum
Jan 19 2021
21.87
Average
21.77
Median
Oct 04 2019
Total Return Price Benchmarks
| NeuBase Therapeutics Inc | 0.4121 |
| iBio Inc | 2.03 |
| Actinium Pharmaceuticals Inc | 8.75 |
| Lixte Biotechnology Holdings Inc | 2.882 |
| Fate Therapeutics Inc | 4.09 |